Stockysis — AI-Powered Stock News & Sentiment Analysis

Chardan Capital Maintains Buy on uniQure, Raises Price Target to $31

Benzinga Newsdesk www.benzinga.com Positive 82.7%

Neg 0% Neu 0% Pos 82.7%

Chardan Capital analyst Daniil Gataulin maintains uniQure (NASDAQ:QURE) with a Buy and raises the price target from $16 to $31.

Comments

No comments yet. Be the first!